Inflammatory lipids as a target for therapy in the rheumatic diseases

M McMahon, E Brahn - Expert opinion on investigational drugs, 2008 - Taylor & Francis
As patients with autoimmune rheumatic diseases live longer due to improved therapies and
preventive measures, death and disability from cardiovascular events are increasing …
被引用次数：19 相关文章

Inflammatory lipids as a target for therapy in the rheumatic diseases

M McMahon, E Brahn - Expert opinion on investigational …, 2008 - pubmed.ncbi.nlm.nih.gov
As patients with autoimmune rheumatic diseases live longer due to improved therapies and
preventive measures, death and disability from cardiovascular events are increasing …

Inflammatory lipids as a target for therapy in the rheumatic diseases.

M McMahon, E Brahn - Expert Opinion on Investigational Drugs, 2008 - europepmc.org
As patients with autoimmune rheumatic diseases live longer due to improved therapies and
preventive measures, death and disability from cardiovascular events are increasing …